Dapagliflozin in the Prevention of Post-Coronary Angioplasty Acute Kidney Injury
Clinical trial NCT05435235 · SUSPENDED
Trial details
- NCT number
- NCT05435235
- Sponsor
- Albert Einstein Healthcare Network
- Status
- SUSPENDED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2025-06-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.